A Safety Study of Abiraterone Acetate Administered in Combination With Docetaxel in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

This study is currently recruiting participants.
Verified April 2014 by Cougar Biotechnology, Inc.
Sponsor:
Information provided by (Responsible Party):
Cougar Biotechnology, Inc.
ClinicalTrials.gov Identifier:
NCT01400555
First received: July 21, 2011
Last updated: April 11, 2014
Last verified: April 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: July 2015
  Estimated Primary Completion Date: November 2014 (Final data collection date for primary outcome measure)
No publications provided by Cougar Biotechnology, Inc.

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):